Financials

  • Market Capitalization 697.17 M
  • Employee 61
  • Founded 2006
  • CEO N/A
  • Website www.zevra.com
  • Headquarter Delaware, United States
  • FIGI BBG0026ZG1F5
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
15.26
Rapporto prezzo/fatturato
6.21

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2698
BBOT
BridgeBio Oncology Therapeutics, Inc. - Common Stock
8.80 USD+0.69%-4.76%+8.11%-2.44%705.53 M USD
2699
STTK
Shattuck Labs, Inc. - Common Stock
7.01 USD-0.43%-12.48%-0.57%+608.08%703.55 M USD
2713
ALLO
Allogene Therapeutics, Inc. - Common Stock
2.00 USD-0.99%-2.44%+6.38%+78.57%690.98 M USD
2717
ASMB
Assembly Biosciences, Inc. - Common Stock
33.63 USD-1.29%-6.58%+33.82%+14.29%684.73 M USD

Notizie